BCPC
Get informed when a big investor buys or sells
+ FollowOvervalued by 0.3% based on the discounted cash flow analysis.
| Market cap | $5.33 Billion |
|---|---|
| Enterprise Value | $5.43 Billion |
| Dividend Yield | $0.96 (0.58%) |
| Earnings per Share | $4.8 |
| Beta | 0.83 |
| Outstanding Shares | 32,284,000 |
| P/E Ratio | 33.86 |
|---|---|
| PEG | 388.2 |
| Price to Sales | 5.19 |
| Price to Book Ratio | 4.26 |
| Enterprise Value to Revenue | 5.13 |
| Enterprise Value to EBIT | 25.65 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.13 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0872▼ 1.71% |
|---|---|
| Total Calls | 56,200▲ 166.35% |
| Total Puts | 4,900▲ 122.73% |
Holdings and activity of institutional investors.
| Ownership % | 88.43%▲ 1.04% |
|---|---|
| Total Invested | $4.84B▲ 10.46% |
| Investors Holding | 427▲ 13.00% |
No data
This powerful committee controls taxation and trade policy, which directly influences Balchem's corporate profitability through tax rates and affects input costs and market access through trade agreements and tariffs.
This committee holds direct legislative and oversight authority over agricultural policy, including the Farm Bill, which profoundly impacts animal agriculture, feed production, and related industries like Balchem's.
This committee oversees the FDA, including the Center for Veterinary Medicine (CVM), which directly regulates animal feed safety, labeling, and manufacturing. Additionally, its oversight of labor laws directly impacts Balchem's operational costs and workforce management.